blog

Ensuring Successful Enrollment of Your Clinical Trials

The market has never been more competitive for small- and mid-size biopharmaceutical companies. While your company may not have the resources or depth of experience as the larger companies, with the right strategies you can find yourself better positioned to deliver results faster and with less expense to reach your clinical trial enrollment goals.

In this free, downloadable ebook, we offer solutions 

Topics: global patient recruitment, Technology, eBook, BBK Worldwide, Patient Recruitment, Patient Retention, Patient Engagement, Trends

When it comes to the benefits travel programs offer in support of clinical trials, opinions are varied. In a recent article published in International Clinical Trials, BBK’s Hannu Koski and Rob Laurens present compelling data with industry insights. “Talking Travel” looks at the appeal travel assistance programs have from the patients’ perspective.

Topics: patient data, Patient Experience, Patient, BBK Worldwide, Patient Recruitment, Patient Retention, Trends, Patient Travel

So much of the focus of clinical trial participation is on the patient and reducing site staff burden. But sometimes we forget about the role of the caregiver. After all, it is usually the caregiver driving the patient to their appointments, managing medication schedules, taking notes at doctor’s appointments, and much more. It makes you wonder: who is the caregiver’s caregiver? Enter Zaggo, a non-profit organization that provides the tools caregivers need to take care of their loved one as effectively and efficiently as possible.

Zaggo was born out of the experience of its founder and president, Roberta Carson, after she was thrust into the role of caregiver for her son Zachary during his 27-month battle with pediatric brain cancer.

Topics: Pharma15, Patient Experience, Most Viewed

Pharma15 Live! jumped at the chance to hear SnapIoT’s Ed Triebell discuss his company’s ground-breaking product, a software platform which allows users to seamlessly connect any smart device to any mobile device—and to any cloud.  

Topics: Pharma15, clinical research, clinical trials, Disruptive Innovation, Conferences, digital, devices, BYOD, provisional device

Pharma15 Live! simply could not resist speaking with Jae Chung, founder of the “Turbo Tax for clinical trials start-up,” goBalto - and his furry friend, the Siberian Husky puppy aptly named Balto. Chung discussed his company’s mission to automate the laborious manual processes related to clinical trial start-up. 

Topics: Pharma15, clinical research, clinical trials, Disruptive Innovation, Conferences, digital, Puppies

Georgia Mitsi spoke with BBK Worldwide’s Aaron Fleishman about her company’s newest app E.V.A — an engagement platform for patients who suffer from chronic neurological conditions. Says Mitsi: “It’s about evaluate, validate and act.”

Topics: Pharma15, clinical research, clinical trials, Disruptive Innovation, digital, devices, BYOD, provisional device, Most Viewed

During this year’s DPharm 2018, Pharma15 Live! met up with Hassan Kadhim, senior associate director and head of IT clinical trial planning and management at Boehringer Ingelheim, before his presentation on the company’s novel remote clinical trial in the respiratory space. Kadhim reflected about the huge changes that he’s seen in the industry just in the past year. 

Topics: Pharma15, clinical research, clinical trials, Disruptive Innovation, Conferences, digital

In the ongoing battle of BYOD (bring-your-own-device) vs. provision devices, Zachary Javitt, CEO and co-founder of PillTracker, has firmly come down on one side.

Topics: Pharma15, clinical research, clinical trials, Disruptive Innovation, Conferences, digital

On Saturday November 3, BBK will be hosting the American Brain Tumor Association’s (ABTA) Boston regional meeting and resource fair at its offices in Needham, Mass. Founded in 1973, ABTA was the first national advocacy organization committed to funding brain tumor research and providing information and education to patients, caregivers, and their loved ones.

For 45 years, ABTA has been providing comprehensive resources that support the complex needs of brain tumor patients and caregivers, as well as the critical funding of research in the pursuit of breakthroughs in brain tumor diagnosis, treatment and care. In anticipation of the upcoming meeting in Boston, we spoke with ABTA Program Manager Christine Daly about the organization and their mission.